Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BELANI, Chandra P")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

Adjuvant and neoadjuvant therapy in non-small cell lung cancerBELANI, Chandra P.Seminars in oncology. 2005, Vol 32, Num 2, pp 9-15, issn 0093-7754, 7 p., SUP2Article

Development of docetaxel in advanced non-small-cell lung cancerBELANI, Chandra P; ECKARDT, John.Lung cancer. 2004, Vol 46, pp s3-s11, issn 0169-5002, SUP2Article

Docetaxel: Uses and Potential Applications in Early-Stage Non-Small-Cell Lung CancerBELANI, Chandra P.Lung cancer. 2004, Vol 46, issn 0169-5002, 49 p., SUP2Serial Issue

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancerSCAGLIOTTI, Giorgio V.Seminars in oncology. 2005, Vol 32, Num 2, pp 5-8, issn 0093-7754, 4 p., SUP2Article

Pemetrexed (akimta) in small cell lung cancerSOCINSKI, Mark A.Seminars in oncology. 2005, Vol 32, Num 2, pp 1-4, issn 0093-7754, 4 p., SUP2Article

Neoadjuvant treatment of early-stage resectable non-small-cell lung cancerBETTICHER, Daniel C; ROSELL, Rafael.Lung cancer. 2004, Vol 46, pp s23-s32, issn 0169-5002, SUP2Article

Adjuvant treatment of lung cancer: current status and potential applications of new regimensLE CHEVALIER, Thierry; LYNCH, Thomas.Lung cancer. 2004, Vol 46, pp s33-s39, issn 0169-5002, SUP2Article

Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerBELANI, Chandra P.Seminars in oncology. 2001, Vol 28, Num 4, pp 14-16, issn 0093-7754, SUP14Article

Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancerSCAGLIOTTI, Giorgio V; DOUILLARD, J.-Y.Lung cancer. 2004, Vol 46, pp s13-s21, issn 0169-5002, SUP2Article

First-line chemotherapy for NSCLC: an overview of relevant trialsBELANI, Chandra P; LANGER, Corey.Lung cancer. 2002, Vol 38, pp S13-S19, issn 0169-5002, SUP4Article

Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging ConsensusOWONIKOKO, Taofeek K; RAMALINGAM, Suresh S; BELANI, Chandra P et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2496-2504, issn 1078-0432, 9 p.Article

Phase 2 Study of Irinotecan and Paclitaxel in Patients With Recurrent or Refractory Small Cell Lung CancerRAMALINGAM, Suresh S; FOSTER, Judy; GOODING, William et al.Cancer. 2010, Vol 116, Num 5, pp 1344-1349, issn 0008-543X, 6 p.Article

Meaningful survival in lung cancer patientsRAMALINGAM, Sakkaraiappan; BELANI, Chandra P.Seminars in oncology. 2002, Vol 29, Num 1, pp 125-131, issn 0093-7754, SUP4Article

Eastern cooperative oncology group experience with chemotherapy in advanced non-small cell lung cancerBONOMI, P.Chest. 1998, Vol 113, Num 1, pp 13S-16S, issn 0012-3692, SUPConference Paper

New chemotherapeutic agents for the treatment of non-small cell lung cancer : The Japanese ExperienceSAIJO, N.Chest. 1998, Vol 113, Num 1, pp 17S-23S, issn 0012-3692, SUPConference Paper

The evolving role of pemetrexed (alimta) in lung cancerSOCINSKI, Mark A; STINCHCOMBE, Thomas E; HAYES, D. Neil et al.Seminars in oncology. 2005, Vol 32, Num 2, pp 16-22, issn 0093-7754, 7 p., SUP2Article

State-of-the-art chemotherapy for advanced non-small cell lung cancerRAMALINGAM, Sakkaraiappan; BELANI, Chandra P.Seminars in oncology. 2004, Vol 31, Num 1, pp 68-74, issn 0093-7754, 7 p., SUP1Article

Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagusAJANI, J. A.Chest. 1998, Vol 113, Num 1, pp 112S-119S, issn 0012-3692, SUPConference Paper

Dose-intensive therapy in small cell lung cancerELIAS, A.Chest. 1998, Vol 113, Num 1, pp 101S-106S, issn 0012-3692, SUPConference Paper

Advances in staging of esophageal carcinomaKRASNA, M. J.Chest. 1998, Vol 113, Num 1, pp 107S-111S, issn 0012-3692, SUPConference Paper

Malignant pleural effusions : Recent Advances and Ambulatory SclerotherapyPATZ, E. F.Chest. 1998, Vol 113, Num 1, pp 74S-77S, issn 0012-3692, SUPConference Paper

Experience with new chemotherapeutic agents in non-small cell lung cancerNATALE, R. B.Chest. 1998, Vol 113, Num 1, pp 32S-39S, issn 0012-3692, SUPConference Paper

Radiation therapy in the management of limited small cell lung cancer : When, where, and how much?WAGNER, H. JR.Chest. 1998, Vol 113, Num 1, pp 92S-100S, issn 0012-3692, SUPConference Paper

Video-assisted thoracoscopic surgery for resection of lung metastasesDOWLING, R. D; LANDRENEAU, R. J; MILLER, D. L et al.Chest. 1998, Vol 113, Num 1, pp 2S-5S, issn 0012-3692, SUPConference Paper

Combined-modality treatment of locally advanced non-small cell lung cancer : Incorporation of Novel Chemotherapeutic AgentsBELANI, C. P; RAMANATHAN, R. K.Chest. 1998, Vol 113, Num 1, pp 53S-60S, issn 0012-3692, SUPConference Paper

  • Page / 3